Forbes William P
SEC CIK 1314760 · EDGAR
BoughtSold
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
| 11 | Forbes William P | EVP, Chief Development Off | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-03 10:59 | 2026-07-30+ | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +23.5K | 244.5K | +11% | — |
| DM | 2026-08-03 10:59 | 2026-07-30+ | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | F - Tax | $0.5 | -6,674 | 241.2K | -3% | -$3,337 |
| D | 2026-07-20 16:10 | 2026-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,874 | 225.5K | +2% | — |
| D | 2026-07-20 16:10 | 2026-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | F - Tax | $0.47 | -1,101 | 224.4K | -0.5% | -$517.47 |
| D | 2026-06-08 10:27 | 2026-06-06 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +12.5K | 221.6K | +6% | — |
| DM | 2026-05-04 12:35 | 2026-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +23.5K | 209.1K | +13% | — |
| D | 2026-04-21 11:15 | 2026-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,874 | 185.6K | +2% | — |
| D | 2026-02-03 | 2026-01-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +11.7K | 181.8K | +7% | — |
| D | 2026-01-20 | 2026-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,875 | 170.1K | +2% | — |
| D | 2025-11-04 | 2025-10-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +11.7K | 166.2K | +8% | — |
| D | 2025-10-21 | 2025-10-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,874 | 154.5K | +3% | — |
| D | 2025-08-04 | 2025-07-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +11.7K | 150.6K | +8% | — |
| D | 2025-07-22 | 2025-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,874 | 138.9K | +3% | — |
| D | 2025-06-09 | 2025-06-06 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +12.5K | 135.1K | +10% | — |
| D | 2025-05-02 | 2025-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +11.7K | 122.6K | +11% | — |
| D | 2025-04-22 | 2025-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,875 | 110.9K | +4% | — |
| D | 2025-01-22 | 2025-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,874 | 107.0K | +4% | — |
| D | 2024-10-21 | 2024-10-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,874 | 103.1K | +4% | — |
| D | 2024-07-22 | 2024-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,875 | 99.2K | +4% | — |
| D | 2024-06-07 | 2024-06-06 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +12.5K | 95.4K | +15% | — |
| D | 2024-04-19 | 2024-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | M - OptEx | — | +3,874 | 82.9K | +5% | — |
| 2023-11-21 | 2023-11-17 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | P - Purchase | $1.09 | +25.0K | 79.0K | +46% | +$27.3K | |
| 2023-11-20 | 2023-11-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Forbes William P | EVP, Chief Development Off | P - Purchase | $0.94 | +50.0K | 54.0K | +1,250% | +$47.0K | |
| 2023-04-03 | 2023-03-31 | XAIR | Beyond Air, Inc. | Forbes William P | Dir | P - Purchase | $6.67 | +5,000 | 14.9K | +51% | +$33.4K | |
| 2023-03-20 | 2023-03-17 | XAIR | Beyond Air, Inc. | Forbes William P | Dir | P - Purchase | $6.46 | +5,000 | 9,855 | +103% | +$32.3K |
Purchase Sale Sale after option exercise All abbreviations